Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. DEFA14A Proxy Proxy Materials
  2. 8-K Event Executive or director change
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. ARS Other Annual Report to Security Holders
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. 4 Planned sale Director sold 959 shares at $21.00 ($20,139)
  8. 144 Insider Sale of Securities
  9. 4 Planned sale Chief Discovery/Trans Medicine sold 32,729 shares at an average $19.82 ($648,824)
  10. 4 Planned sale COO and General Counsel sold 37,184 shares at an average $19.80 ($736,059)
  11. 4 Planned sale Chief Financial Officer sold 45,167 shares at an average $19.77 ($893,095)
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 4 Planned sale Chief Executive Officer sold 11,520 shares at $19.05 ($219,456)
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 8 of 69 · 1,363 filings